The randomized, double-blind, placebo-controlled crossover study included healthy adults aged 35 - 65 years of age. The aim was to evaluate the effect of SuperUlam on attention, concentration, memory and mood state in sleep-deprived healthy volunteers compared to placebo.
Measurement of cognitive function included computer-based testing of reaction time, complex attention, working memory, sustained attention, and executive functioning. The study concluded that supplementation with SuperUlam is safe to consume with potential benefits to cognitive function and mood.
“The SuperUlam product appears to have a neurostimulatory and neurocognitive performance enhancement effect, impacting various aspects of cognition and memory at different times between one and five hours after a single dose,” said principal investigator, Dr. Jay Udani, CEO and medical director of Medicus Research. “The product also appears to induce a state of relaxation as evidenced by reductions in tension, anger, and depression.”
For more information: www.biotropicsingredients.com